Pharmaceutical combination for treating tumor

Details for Australian Patent Application No. 2010296307 (hide)

Owner Sucampo AG

Inventors Ueno, Ryuji

Agent Davies Collison Cave

Pub. Number AU-A-2010296307

PCT Pub. Number WO2011/034210

Priority 61/243,019 16.09.09 US

Filing date 16 September 2010

Wipo publication date 24 March 2011

International Classifications

A61K 31/5575 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

5 April 2012 PCT application entered the National Phase

  PCT publication WO2011/034210 Priority application(s): WO2011/034210

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010296312-Compounds having TAFIa inhibitory activity

2010296299-Chromene compound